Despite the FDA’s CNPV scheme generating high interest, the process around how voucher awards are prioritised remains unclear ...

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...

The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...

There’s no doubt that large language models and generative AI tools have taken the world by storm. Their ability to create, ...

In a group of health-related headlines, one says "Hope for new drug approach. As government-supported research in the US is being decimated by funding cuts, it was refreshing to attend iDR25 (the ...

SAN FRANCISCO, Jan 26 (Reuters) - Artificial intelligence has yet to deliver on the most challenging aspect of drug development -- finding new molecules that lead to major medical advances -- but it ...

A major step toward simpler drug development has been taken at the University of Gothenburg. In a new study, researchers have developed stable boron-fluorine compounds that make it possible to ...

Pharmaceutical innovation saves lives. But not every "new" drug is truly new. Such practices raise concerns about drug access and affordability, especially when companies use minor tweaks to block ...

In a year from now, progress is to be measured in the institutionalisation of the approach with greater regulatory acceptance ...